颅内动静脉畸形和硬脑膜动静脉瘘的血管内治疗。

Endovascular treatment of cranial arteriovenous malformations and dural arteriovenous fistulas.

机构信息

Division of Interventional Neuroradiology, The Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21287, USA.

出版信息

Neurosurg Clin N Am. 2012 Jan;23(1):123-31. doi: 10.1016/j.nec.2011.09.009.

DOI:10.1016/j.nec.2011.09.009

PMID:22107863

Abstract

Pial arteriovenous malformations (AVMs) and dural arteriovenous fistulas (DAVFs) are high-flow vascular lesions with abnormal communications between the arterial and venous system. AVMs are congenital lesions, whereas DAVFs are considered acquired lesions. Both can cause significant morbidity and mortality if they rupture and result in intracranial hemorrhage. The primary goal of treatment is to eliminate the risk of bleeding or at least decrease it. Because the epidemiology, clinical presentation, and classification of AVMs and DAVFs have been covered in previous articles in this issue, the authors only briefly touch on these subjects as they relate to endovascular treatment.

摘要

脑表面动静脉畸形（AVM）和硬脑膜动静脉瘘（DAVF）是一种高流量的血管病变，其特点是动脉和静脉系统之间存在异常交通。AVM 是先天性病变，而 DAVF 被认为是获得性病变。如果破裂导致颅内出血，两者都会造成严重的发病率和死亡率。治疗的主要目标是消除出血风险，或者至少降低出血风险。由于本期刊物中的其他文章已经涵盖了 AVM 和 DAVF 的流行病学、临床表现和分类，因此作者仅简要提及这些内容与血管内治疗的关系。